• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喀麦隆雅温得的 COVID-19 临床特征及相关因素:一项前瞻性队列研究。

Clinical profile and factors associated with COVID-19 in Yaounde, Cameroon: A prospective cohort study.

机构信息

Afyabora consortium, University of Buea, Buea, Cameroon.

Public Health Emergency and Operations Centre (PHEOC), Ministry of Public Health, Yaounde, Cameroon.

出版信息

PLoS One. 2021 May 12;16(5):e0251504. doi: 10.1371/journal.pone.0251504. eCollection 2021.

DOI:10.1371/journal.pone.0251504
PMID:33979402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8115782/
Abstract

BACKGROUND

A year after the COVID-19 pandemic started, there are still few scientific reports on COVID-19 in Africa. This study explores the clinical profiles and factors associated with COVID-19 in Cameroon.

MATERIALS AND METHODS

In this prospective cohort study, we followed patients admitted for suspicion of COVID-19 at Djoungolo Hospital between 01st April and 31st July 2020. Patients were categorised by age groups and disease severity: mild (symptomatic without clinical signs of pneumonia), moderate (with clinical signs of pneumonia without respiratory distress) and severe cases (clinical signs of pneumonia and respiratory distress not requiring invasive ventilation). Demographic information and clinical features were summarised. Multivariable analysis was performed to predict risk.

FINDINGS

A total of 313 patients were admitted during the study period; 259 were confirmed cases of COVID-19 by Polymerase Chain Reaction (PCR). Among the confirmed cases, the male group aged 40 to 49 years (13.9%) was predominant. Disease severity ranged from mild (26.2%; n = 68) to moderate (59%; n = 153) to severe (14.7%; n = 38); the case fatality rate was 1% (n = 4). Dysgusia (46%; n = 119) and hyposmia/anosmia (37.8%; n = 98) were common features of COVID-19. Nearly one-third of patients had comorbidities (29%; n = 53), of which hypertension was the most common (18.9%; n = 49). Participation in mass gatherings (Odds Ratio (OR) = 2.37; P = 0.03) and dysgusia (OR = 2.09, P = 0.02) were predictive of diagnosis of COVID-19. Age groups 60 to 69 (OR = 7.41; P = 0.0001), 50 to 59 (OR = 4.09; P = 0.03), 40 to 49 (OR = 4.54; P = 0.01), male gender (OR = 2.53; P = 0.04), diabetes (OR = 4.05; P = 0.01), HIV infection (OR = 5.57; P = 0.03), lung disease (OR = 6.29; P = 0.01), dyspnoea (OR = 3.70; P = 0.008) and fatigue (OR = 3.35; P = 0.02) significantly predicted COVID-19 severity.

CONCLUSIONS

Most COVID-19 cases in this study were benign with low fatality. Age (40-70), male gender, HIV infection, lung disease, dyspnoea and fatigue are associated with severe COVID-19. Such findings may guide public health decision-making.

摘要

背景

在 COVID-19 大流行开始一年后,非洲仍鲜有关于 COVID-19 的科学报告。本研究探讨了喀麦隆 COVID-19 的临床特征和相关因素。

材料和方法

在这项前瞻性队列研究中,我们对 2020 年 4 月 1 日至 7 月 31 日期间在 Djoungolo 医院因疑似 COVID-19 而入院的患者进行了随访。患者按年龄组和疾病严重程度进行分类:轻症(有症状但无肺炎临床体征)、中度(有肺炎临床体征但无呼吸窘迫)和重症(有肺炎临床体征和呼吸窘迫但无需侵入性通气)。总结了人口统计学信息和临床特征。进行了多变量分析以预测风险。

结果

在研究期间共有 313 名患者入院;259 名经聚合酶链反应(PCR)确诊为 COVID-19。在确诊病例中,40 至 49 岁的男性组(13.9%)居多。疾病严重程度从轻症(26.2%;n=68)到中度(59%;n=153)到重症(14.7%;n=38)不等;病死率为 1%(n=4)。味觉障碍(46%;n=119)和嗅觉减退/丧失(37.8%;n=98)是 COVID-19 的常见特征。近三分之一的患者有合并症(29%;n=53),其中高血压最常见(18.9%;n=49)。参加群众集会(优势比(OR)=2.37;P=0.03)和味觉障碍(OR=2.09,P=0.02)与 COVID-19 的诊断有关。60 至 69 岁年龄组(OR=7.41;P=0.0001)、50 至 59 岁年龄组(OR=4.09;P=0.03)、40 至 49 岁年龄组(OR=4.54;P=0.01)、男性(OR=2.53;P=0.04)、糖尿病(OR=4.05;P=0.01)、HIV 感染(OR=5.57;P=0.03)、肺部疾病(OR=6.29;P=0.01)、呼吸困难(OR=3.70;P=0.008)和疲劳(OR=3.35;P=0.02)显著预测 COVID-19 严重程度。

结论

本研究中的大多数 COVID-19 病例均为良性,病死率低。年龄(40-70 岁)、男性、HIV 感染、肺部疾病、呼吸困难和疲劳与严重 COVID-19 相关。这些发现可能为公共卫生决策提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55fe/8115782/37530b063c42/pone.0251504.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55fe/8115782/025a8bd2cc4f/pone.0251504.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55fe/8115782/e2b47136cdac/pone.0251504.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55fe/8115782/37530b063c42/pone.0251504.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55fe/8115782/025a8bd2cc4f/pone.0251504.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55fe/8115782/e2b47136cdac/pone.0251504.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55fe/8115782/37530b063c42/pone.0251504.g003.jpg

相似文献

1
Clinical profile and factors associated with COVID-19 in Yaounde, Cameroon: A prospective cohort study.喀麦隆雅温得的 COVID-19 临床特征及相关因素:一项前瞻性队列研究。
PLoS One. 2021 May 12;16(5):e0251504. doi: 10.1371/journal.pone.0251504. eCollection 2021.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
4
Early prediction of level-of-care requirements in patients with COVID-19.对 COVID-19 患者的医疗照护需求进行早期预测。
Elife. 2020 Oct 12;9:e60519. doi: 10.7554/eLife.60519.
5
[Clinical features and predictors of severity in 1022 adults with COVID-19].1022例新型冠状病毒肺炎成年患者的临床特征及病情严重程度预测因素
Rev Med Chil. 2020 Oct;148(10):1387-1397. doi: 10.4067/S0034-98872020001001387.
6
Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City.COVID-19 成年住院患者死亡率的预测因素:来自纽约市的回顾性队列研究。
West J Emerg Med. 2020 Jul 8;21(4):779-784. doi: 10.5811/westjem.2020.6.47919.
7
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
8
Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.在新冠疫情早期,一家筛查诊所的冠状病毒病(COVID-19)病例的流行病学和临床特征:一项单中心研究。
J Med Microbiol. 2020 Aug;69(8):1114-1123. doi: 10.1099/jmm.0.001231.
9
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
10
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.一项评估巴瑞替尼预防 COVID19 相关血液肿瘤患者呼吸功能不全进展的疗效的 I/II 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):116. doi: 10.1186/s13063-021-05072-4.

引用本文的文献

1
Characteristics, management and factors associated with poor outcomes in COVID-19 patients in Burkina Faso: insights from a 2021 large-scale ambispective study.布基纳法索新冠肺炎患者的特征、管理及与不良结局相关的因素:来自2021年一项大规模双向性研究的见解
Front Public Health. 2025 Jul 10;13:1542024. doi: 10.3389/fpubh.2025.1542024. eCollection 2025.
2
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon.新冠病毒动力学及与新冠病毒阳性持续时间相关的因素:来自喀麦隆前三波疫情的证据
BMC Infect Dis. 2025 May 5;25(1):660. doi: 10.1186/s12879-025-11048-5.
3

本文引用的文献

1
Clinical and epidemiological characteristics and outcomes of patients hospitalized for COVID-19 in Douala, Cameroon.喀麦隆杜阿拉住院 COVID-19 患者的临床和流行病学特征及转归。
Pan Afr Med J. 2021 Mar 8;38:246. doi: 10.11604/pamj.2021.38.246.28169. eCollection 2021.
2
African authorship on African papers during the COVID-19 pandemic.新冠疫情期间非洲论文的非洲作者身份。
BMJ Glob Health. 2021 Mar;6(3). doi: 10.1136/bmjgh-2020-004612.
3
Risk factors of the severity of COVID-19: A meta-analysis.新冠病毒(COVID-19)严重程度的风险因素:一项荟萃分析。
Status of infection prevention and control in Cameroon healthcare facilities: lessons learned from the WHO COVID-19 scorecard tool under the hierarchy of control model.
喀麦隆医疗机构的感染预防与控制状况:从控制模型层级下的世卫组织新冠疫情记分卡工具中吸取的经验教训
Infect Prev Pract. 2024 Oct 28;6(4):100407. doi: 10.1016/j.infpip.2024.100407. eCollection 2024 Dec.
4
Outcome of hospitalized patients with COVID-19 and predictors at the Buea Regional Hospital, South West region of Cameroon.喀麦隆西南部布埃亚地区医院住院 COVID-19 患者的结局和预测因素。
Pan Afr Med J. 2024 Apr 4;47:165. doi: 10.11604/pamj.2024.47.165.34572. eCollection 2024.
5
Diabetes mellitus in sub-saharan Africa during the COVID-19 pandemic: A scoping review.撒哈拉以南非洲在 COVID-19 大流行期间的糖尿病:范围综述。
PLoS One. 2024 Jul 8;19(7):e0305112. doi: 10.1371/journal.pone.0305112. eCollection 2024.
6
Demographic characteristics, clinical presentation and in-hospital outcome among patients with Covid-19 in a Nigerian tertiary hospital.尼日利亚一家三级医院的新冠病毒患者的人口统计学特征、临床表现和住院结局。
Malawi Med J. 2023 Mar;35(1):43-57. doi: 10.4314/mmj.v35i1.8.
7
Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon.对 SARS-CoV-2 的基因组监测显示,德尔塔变体的严重程度和死亡率均高于其他变体:来自喀麦隆的证据。
Sci Rep. 2023 Dec 8;13(1):21654. doi: 10.1038/s41598-023-48773-3.
8
[Epidemiological characteristics of the Covid-19 epidemic between 2020 and 2022 in Kongo central, DRC].[2020年至2022年刚果民主共和国中刚果省新冠疫情的流行病学特征]
Med Trop Sante Int. 2023 Apr 18;3(2). doi: 10.48327/mtsi.v3i2.2023.356. eCollection 2023 Jun 30.
9
Epidemiological, clinical, therapeutic features and predictors of death among COVID-19 patients hospitalized in Parakou: a cross-sectional study in Northern Benin.贝宁北部帕拉库医院收治的 COVID-19 患者的流行病学、临床、治疗特征和死亡预测因素:横断面研究。
BMC Infect Dis. 2023 Jul 20;23(1):484. doi: 10.1186/s12879-023-08445-z.
10
Epidemiological situation of SARS-CoV-2 infection in Douala, the most populated and highly heterogeneous town of Cameroon: a post-vaccination update.喀麦隆人口最多且高度多样化的城镇杜阿拉的 2019 年冠状病毒病感染的流行病学情况:疫苗接种后的最新情况。
Acta Trop. 2023 May;241:106864. doi: 10.1016/j.actatropica.2023.106864. Epub 2023 Feb 26.
Int J Clin Pract. 2021 Jul;75(7):e13916. doi: 10.1111/ijcp.13916. Epub 2020 Dec 20.
4
COVID-19 length of hospital stay: a systematic review and data synthesis.COVID-19 住院时间:系统评价和数据综合。
BMC Med. 2020 Sep 3;18(1):270. doi: 10.1186/s12916-020-01726-3.
5
Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes.COVID-19性别特异性临床结局的系统评价与Meta分析
Front Med (Lausanne). 2020 Jun 23;7:348. doi: 10.3389/fmed.2020.00348. eCollection 2020.
6
COVID-19 Contact Tracing Solutions for Mass Gatherings.大规模集会的 COVID-19 接触者追踪解决方案。
Disaster Med Public Health Prep. 2021 Jun;15(3):e1-e7. doi: 10.1017/dmp.2020.241. Epub 2020 Jul 14.
7
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.24410 名新型冠状病毒(SARS-CoV-2;COVID-19)感染者的症状流行率:来自 9 个国家的 148 项研究的系统评价和荟萃分析。
PLoS One. 2020 Jun 23;15(6):e0234765. doi: 10.1371/journal.pone.0234765. eCollection 2020.
8
COVID-19 and comorbidities: a systematic review and meta-analysis.COVID-19 与合并症:系统评价和荟萃分析。
Postgrad Med. 2020 Nov;132(8):749-755. doi: 10.1080/00325481.2020.1786964. Epub 2020 Jul 14.
9
Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies.糖尿病是 COVID-19 病情加重和住院死亡的危险因素:观察性研究的荟萃分析。
Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1236-1248. doi: 10.1016/j.numecd.2020.05.014. Epub 2020 May 29.
10
Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence.因冠状病毒病(COVID-19)引起的嗅觉和味觉障碍:当前证据综述。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):307-312. doi: 10.1007/s00405-020-06120-6. Epub 2020 Jun 17.